BUPICAN

This brand name is authorized in Brazil, Estonia, South Africa.

Active ingredients

The drug BUPICAN contains one active pharmaceutical ingredient (API):

1	Bupivacaine UNII 7TQO7W3VT8 - BUPIVACAINE HYDROCHLORIDE
	Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.
	Read more about Bupivacaine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BUPICAN Solution for injection	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01BB01	Bupivacaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	533021090075717, 533021090075817, 534100501156410
EE	Ravimiamet	1784910
ZA	Health Products Regulatory Authority	45/4/0127